GlucoTrack Inc. (GCTK)
0.59
-0.05 (-8.23%)
At close: Feb 10, 2025, 10:53 AM
undefined% (undefined)
| Bid | 0.59 |
| Market Cap | 4.62M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -58.2 |
| PE Ratio (ttm) | -0.01 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.61 |
| Volume | 521,504 |
| Avg. Volume (20D) | 3,279,240 |
| Open | 0.62 |
| Previous Close | 0.64 |
| Day's Range | 0.59 - 0.65 |
| 52-Week Range | 0.48 - 99.00 |
| Beta | undefined |
About GCTK
GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its na...
Industry Medical - Instruments & Supplies
Sector Healthcare
IPO Date Apr 25, 2013
Employees 6
Stock Exchange NASDAQ
Ticker Symbol GCTK
Website https://www.glucotrack.com
6 days ago
-28.95%
Glucotrack shares are trading lower after the comp...
Unlock content with
Pro Subscription
1 week ago
+2.19%
GlucoTrack shares are trading higher. The company announced it appointed Peter Wulff As CFO.
